INTERVIEW: Novartis' Oncology Chief On Sharpening Its Competitive Advantage

Novartis Oncology President Bruno Strigini talks about refining the pharma major's oncology strategy and its pipeline potential.

Cancer cell

Novartis’s oncology portfolio sales, by product ($m), 2015–25

Open Media

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Anticancer

More from Therapeutic Category